This announcement is a separate document:
迈普医学：上海信公轶禾企业管理咨询有限公司关于广州迈普再生医学科技股份有限公司2024年限制性股票激励计划首次授予相关事项之独立财务顾问报告
Medprin Regenerative Medical Technologies: Independent financial advisor report on the first grant of Guangzhou Maple Resurrection Medical Technology Co., Ltd.'s 2024 Restricted Stock Incentive Plan, by Shanghai Xingongyihe Enterprise Management Consulting Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.